Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Eisai and Johns Hopkins to collaborate on development GCPII inhibitors

March 16, 2010

Ipsen grants Rhythm worldwide license for two programs in metabolic disorders

March 15, 2010

Trillium expands immunology pipeline and enters stem cell field

March 15, 2010

Medivir outlicenses hepatitis B therapeutic MIV-210 to Daewoong

March 12, 2010

BioInvent and Human Genome Sciences enter collaboration for monoclonal antibodies

March 12, 2010

Biomoda and Obio collaborate to expand lung cancer screening program

March 12, 2010

Affymax receives milestone payment from Takeda for phase III Hematide trial in Japan

March 11, 2010

Transgene signs exclusive option agreement with Novartis for NSCLC therapeutic TG-4010

March 11, 2010

Cellzome and GSK enter strategic drug discovery alliance in inflammatory disease

March 11, 2010

Abbott and GSK to develop molecular diagnostic test for skin cancer treatment

March 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...